AB
VTYX

Amalgamated Bank’s Ventyx Biosciences VTYX Stock Holding History

Amalgamated Bank’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,594
Closed -$2K – 3159
2025
Q1 		$2K Hold
1,594
– – ﹤0.01% 2883
2024
Q4 		$3K Hold
1,594
– – ﹤0.01% 2885
2024
Q3 		$3K Hold
1,594
– – ﹤0.01% 2912
2024
Q2 		$4K Hold
1,594
– – ﹤0.01% 2894
2024
Q1 		$9K Sell
1,594
-5,048
-76% -$23.1K ﹤0.01% 2503
2023
Q4 		$16K Sell
6,642
-475
-7% -$4.51K ﹤0.01% 2755
2023
Q3 		$247K Buy
7,117
+901
+14% +$31.1K ﹤0.01% 1709
2023
Q2 		$204K Buy
6,216
+2,692
+76% +$92.8K ﹤0.01% 1817
2023
Q1 		$118K Sell
3,524
-683
-16% -$26.6K ﹤0.01% 1989
2022
Q4 		$138K Buy
4,207
+610
+17% +$18.1K ﹤0.01% 1999
2022
Q3 		$126K Buy
3,597
+54
+2% +$1.2K ﹤0.01% 2047
2022
Q2 		$43K Buy
3,543
+2,027
+134% +$30.3K ﹤0.01% 2562
2022
Q1 		$21K Buy
+1,516
New +$20.3K ﹤0.01% 2798

Other funds holding VTYX

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Amalgamated Bank's VTYX Position: Q2 2025 in Review

Amalgamated Bank sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 1,594 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in VTYX in Q1 2022 and held it in 13 quarters. The position peaked at $247K in Q3 2023. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

  • Amalgamated Bank reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 1,594 Ventyx Biosciences shares in Q2 2025, an estimated $2K.
  • Amalgamated Bank first reported a position in Ventyx Biosciences in Q1 2022 and held it in 13 quarters.
  • Amalgamated Bank's Ventyx Biosciences position peaked at $247K in Q3 2023.
  • 114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.